Fiscal Years 2021–2023
- Business
Takeda Completes Sale of TachoSil® to Corza Health
Osaka, Japan: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has completed the previously announced sale of TachoSil® Fibrin Sealant Patch…
Read More »